These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Surfactant replacement in preterm infants with respiratory distress syndrome. Dani C Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871 [TBL] [Abstract][Full Text] [Related]
45. [Surfactant replacement therapy in neonatal respiratory distress syndrome: prophylactic therapy versus treating of established disease]. Lubetzky R; Dolberg S Harefuah; 1999 Nov; 137(10):464-7. PubMed ID: 10959346 [No Abstract] [Full Text] [Related]
46. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study]. Shinwell ES; Zmora E; Leven D; Berger I; Karplus M Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835 [TBL] [Abstract][Full Text] [Related]
47. [Biochemical diagnosis of the state of the surfactant system in the fetal and newborn lungs]. Lariushkina RM; Pukhovskaia NV Pediatriia; 1980; (1):9-12. PubMed ID: 6892956 [No Abstract] [Full Text] [Related]
48. Economic consequences of surfactant therapy. Eidelman AI J Perinatol; 1993; 13(2):137-9. PubMed ID: 8515307 [No Abstract] [Full Text] [Related]